ANGIODYNAMICS INC
For the period ended May 31, 2025. Filed Jul 18, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Jul 18, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
(a)(1) Financial Statements
The following consolidated financial statements and supplementary data of Registrant and its subsidiaries required by Part II, Item 8, are included in Part IV of this report:
| Report of Independent Registered Public Accounting Firm (PCAOB ID 34) | 50 |
|---|---|
| Consolidated Statements of Operations—Year ended May 31, 2025, 2024 and 2023 | 52 |
| Consolidated Statements of Comprehensive Loss - Year ended May 31, 2025, 2024 and 2023 | 53 |
| Consolidated Balance Sheets—May 31, 2025 and May 31, 2024 | 54 |
| Consolidated Statements of Stockholders’ Equity—Year ended May 31, 2025, 2024 and 2023 | 55 |
| Consolidated Statements of Cash Flows—Year ended May 31, 2025, 2024 and 2023 | 56 |
| Notes to Consolidated Financial Statements | 58 |
(2) Financial Statement Schedules
The following consolidated financial statement schedule is included in Part IV of this report:
| Schedule II—Valuation and qualifying accounts | 81 |
|---|
All other schedules are omitted because they are not applicable, not required, or because the required information is included in the consolidated financial statements or notes thereto.
| (b) Exhibits | 82 |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.